DK1328266T3 - Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion - Google Patents

Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion

Info

Publication number
DK1328266T3
DK1328266T3 DK01988586T DK01988586T DK1328266T3 DK 1328266 T3 DK1328266 T3 DK 1328266T3 DK 01988586 T DK01988586 T DK 01988586T DK 01988586 T DK01988586 T DK 01988586T DK 1328266 T3 DK1328266 T3 DK 1328266T3
Authority
DK
Denmark
Prior art keywords
fenofibrate
coenzyme
combination
endothelial dysfunction
treat endothelial
Prior art date
Application number
DK01988586T
Other languages
Danish (da)
English (en)
Inventor
Gerald Watts
David Playford
Original Assignee
Fournier Lab Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR1038A external-priority patent/AUPR103800A0/en
Priority claimed from AUPR3424A external-priority patent/AUPR342401A0/en
Application filed by Fournier Lab Ireland Ltd filed Critical Fournier Lab Ireland Ltd
Application granted granted Critical
Publication of DK1328266T3 publication Critical patent/DK1328266T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01988586T 2000-10-26 2001-10-23 Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion DK1328266T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR1038A AUPR103800A0 (en) 2000-10-26 2000-10-26 Compositions for the treatment of endothelial dysfunction
AUPR3424A AUPR342401A0 (en) 2001-02-28 2001-02-28 Compositions for the treatment of endothelial dysfunction

Publications (1)

Publication Number Publication Date
DK1328266T3 true DK1328266T3 (da) 2006-06-06

Family

ID=25646491

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01988586T DK1328266T3 (da) 2000-10-26 2001-10-23 Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion

Country Status (30)

Country Link
US (1) US7410983B2 (fr)
EP (1) EP1328266B1 (fr)
JP (1) JP4236464B2 (fr)
KR (1) KR100862129B1 (fr)
CN (1) CN1220488C (fr)
AR (1) AR035071A1 (fr)
AT (1) ATE316787T1 (fr)
AU (1) AU2176502A (fr)
BG (1) BG65979B1 (fr)
BR (1) BR0114701A (fr)
CA (1) CA2426625C (fr)
CY (1) CY1105007T1 (fr)
CZ (1) CZ301282B6 (fr)
DE (1) DE60117046T2 (fr)
DK (1) DK1328266T3 (fr)
DZ (1) DZ3442A1 (fr)
EE (1) EE05281B1 (fr)
ES (1) ES2257457T3 (fr)
HK (1) HK1057340A1 (fr)
HU (1) HUP0303566A3 (fr)
IL (2) IL155524A0 (fr)
MA (1) MA25847A1 (fr)
MX (1) MXPA03003733A (fr)
NO (1) NO332260B1 (fr)
PL (1) PL212952B1 (fr)
PT (1) PT1328266E (fr)
RU (1) RU2003111175A (fr)
SK (1) SK287992B6 (fr)
TN (1) TNSN01151A1 (fr)
WO (1) WO2002034259A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE360417T1 (de) 2001-07-11 2007-05-15 Boehringer Ingelheim Pharma Methode zur behandlung von zytokinvermittelten erkrankungen
WO2003075911A1 (fr) * 2002-03-11 2003-09-18 Peter Zahradka Utilisation d'agonistes de ppar alpha dans le traitement de maladies vasculaires et renales
US20070225614A1 (en) * 2004-05-26 2007-09-27 Endothelix, Inc. Method and apparatus for determining vascular health conditions
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
GB0309154D0 (en) * 2003-01-14 2003-05-28 Aventis Pharma Inc Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia
JP2005104951A (ja) * 2003-01-17 2005-04-21 Kirin Brewery Co Ltd 血圧降下用組成物および血管柔軟性改善用組成物並びにこれらの機能が付与された食品
FR2868313B1 (fr) * 2004-03-31 2008-08-15 Servier Lab Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
EP1621200A1 (fr) * 2004-07-26 2006-02-01 Fournier Laboratories Ireland Limited Combinaison pharmaceutique comprenant un inhibiteur de l'aggregation des thrombocytes et un fibrate
ES2619303T3 (es) 2005-06-01 2017-06-26 Edison Pharmaceuticals, Inc. Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
EP1785133A1 (fr) * 2005-11-10 2007-05-16 Laboratoires Fournier S.A. Utilisation du fenofibrate ou d'un de ses dérivés pour la prevention de la retinopathie diabetique
EP1986636B1 (fr) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Derives du phenol et de la 1,4-benzoquinone pour leur utilisation dans le traitement des maladies mitochondriales
WO2007106912A2 (fr) * 2006-03-16 2007-09-20 University Of Pittsburgh Of The Commonwealth System Of Higher Education Agonistes du récepteur-alpha activé de la prolifération des peroxysomes pour la conservation d'organe
US20070225606A1 (en) * 2006-03-22 2007-09-27 Endothelix, Inc. Method and apparatus for comprehensive assessment of vascular health
US20080027330A1 (en) * 2006-05-15 2008-01-31 Endothelix, Inc. Risk assessment method for acute cardiovascular events
US20080081963A1 (en) * 2006-09-29 2008-04-03 Endothelix, Inc. Methods and Apparatus for Profiling Cardiovascular Vulnerability to Mental Stress
KR100989093B1 (ko) 2008-01-18 2010-10-25 한화제약주식회사 생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
LT3827815T (lt) 2008-09-10 2023-10-10 Ptc Therapeutics, Inc. Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais
US20110305755A1 (en) * 2009-01-29 2011-12-15 Levine Joshua D Method of adding botanical agents/dietary supplements to pharmaceutical agents in a pharmacotherapeutic regimen
US8973851B2 (en) 2009-07-01 2015-03-10 The Procter & Gamble Company Apparatus and methods for producing charged fluid droplets
US8772349B2 (en) * 2010-03-26 2014-07-08 Vivacell Biotechnology Espana, S.L. Cannabinoid quinone derivatives
RU2554500C2 (ru) * 2013-09-20 2015-06-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ лечения ишемического инсульта
AU2016369616B2 (en) 2015-12-17 2021-03-25 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
WO2019084540A1 (fr) 2017-10-27 2019-05-02 Zeta Biolongevity, Inc. Compositions et méthodes pour traiter et prévenir la protéinurie et l'érosion endothéliale
CN110907407B (zh) * 2019-12-03 2022-02-25 东北石油大学 一种基于spr的高灵敏度光子准晶体光纤折射率传感器

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229385A (en) 1986-01-30 1993-07-20 Takeda Chemical Industries, Ltd. Quinone derivatives, their production and use
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FI102273B1 (fi) 1989-09-11 1998-11-13 Eisai Co Ltd Kinonijohdannaiset, niiden valmistaminen ja niiden farmakologinen käyttö
FR2730231B1 (fr) * 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
WO1997028149A1 (fr) * 1996-02-02 1997-08-07 Merck & Co., Inc. Procede pour augmenter les niveaux de cholesterol hdl
GB9606805D0 (en) 1996-03-30 1996-06-05 Glaxo Wellcome Inc Medicaments
WO1999027952A1 (fr) 1997-11-28 1999-06-10 Nikolai Vasilievich Karsanov Produit anti-hypoxique et anti-ischemique
US6423742B1 (en) * 1999-09-02 2002-07-23 Drake Larson Compositions for reducing vascular plaque formation and methods of using same

Also Published As

Publication number Publication date
WO2002034259A1 (fr) 2002-05-02
SK5082003A3 (en) 2003-11-04
CZ301282B6 (cs) 2009-12-30
AU2176502A (en) 2002-05-06
CN1471390A (zh) 2004-01-28
BG65979B1 (bg) 2010-08-31
ES2257457T3 (es) 2006-08-01
HUP0303566A2 (hu) 2004-03-01
HK1057340A1 (en) 2004-04-02
DE60117046T2 (de) 2006-09-28
ATE316787T1 (de) 2006-02-15
PL212952B1 (pl) 2012-12-31
DZ3442A1 (fr) 2002-05-02
CY1105007T1 (el) 2009-11-04
HUP0303566A3 (en) 2005-05-30
US7410983B2 (en) 2008-08-12
EP1328266A1 (fr) 2003-07-23
DE60117046D1 (de) 2006-04-13
PL361635A1 (en) 2004-10-04
MA25847A1 (fr) 2003-07-01
NO20031851L (no) 2003-06-24
BG107765A (bg) 2004-02-27
IL155524A (en) 2008-08-07
KR20030055276A (ko) 2003-07-02
PT1328266E (pt) 2006-05-31
NO20031851D0 (no) 2003-04-24
TNSN01151A1 (en) 2005-11-10
EP1328266B1 (fr) 2006-02-01
CA2426625A1 (fr) 2002-05-02
SK287992B6 (sk) 2012-09-03
RU2003111175A (ru) 2004-09-10
NO332260B1 (no) 2012-08-13
BR0114701A (pt) 2003-11-18
JP2004512302A (ja) 2004-04-22
IL155524A0 (en) 2003-11-23
JP4236464B2 (ja) 2009-03-11
MXPA03003733A (es) 2004-10-15
CA2426625C (fr) 2010-06-01
EE05281B1 (et) 2010-04-15
AR035071A1 (es) 2004-04-14
KR100862129B1 (ko) 2008-10-09
CN1220488C (zh) 2005-09-28
EE200300165A (et) 2003-06-16
US20040022778A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
DK1328266T3 (da) Kombination af fenofibrat og coenzym Q10 til behandling af endothelial dysfunktion
ATE424413T1 (de) Analoge des glucagon-ähnlichen peptids-1
DE60111534D1 (de) Alpha-acyl- und alpha-heteroatom-substituierte benzenacetamide verwendbar als glucokinase-aktivatoren
DE10194333T1 (de) Methode des Quantenrechnens
ID30590A (id) Celana sekali pakai jenis-celana pendek
DK1212317T3 (da) Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
DK1334182T4 (da) Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
DE60128652D1 (de) Prostatischer stent zur erleichterung der drainage
DE60106968D1 (de) Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
DE50112129D1 (de) Wasserklosett
DK1248608T3 (da) Diacerein til anvendelse i behandling af psoriasis
NO20023467L (no) Alkylbenzensulfonater på fast form og rensesammensetninger med ökt vannhardhetstoleranse
DE60107627D1 (de) Sauerstoff und Wasserdampf absorbierende Zusammensetzung
DK1345598T3 (da) Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser
DE50112505D1 (de) Schäranlage und Schärverfahren
NO20030978D0 (no) Behandling av diuresedysfunksjon
DK1381620T3 (da) Hypersulfaterede disaccharider og fremgangsmåder til anvendelse af samme til behandling af inflammationer
PT1273556E (pt) Estacao de tratamento simbiotico de aguas residuais.
DK1259515T3 (da) Thienopyridinderivater og deres anvendelse som antiinflammatoriske midler
DK1228027T3 (da) 3-heteroatomsubstituerede og to carbonhomologe af 15-HETE og fremgangsmåder til anvendelse
DK1680405T3 (da) Bengamidderivater og deres anvendelse til behandling af kræftsygdomme
ATA2102000A (de) Wasserklosett
FI20030276A (fi) Palovammojen hoitaminen
ATA10412001A (de) Kleinkläranlage